These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16611318)

  • 1. The use of rituximab in two children with allo-antibodies towards factor VIII.
    Curry N; Stanworth S; Keeling D
    Br J Haematol; 2006 Apr; 133(2):214-6. PubMed ID: 16611318
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
    Mathias M; Khair K; Hann I; Liesner R
    Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab in the treatment of acquired factor VIII inhibitors.
    Onitilo AA; Skorupa A; Lal A; Ronish E; Mercier RJ; Islam R; Lazarchick J
    Thromb Haemost; 2006 Jul; 96(1):84-7. PubMed ID: 16807656
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of inhibitor against hemophilia and prevention and management strategies forpatients with hemophilia].
    Wu RH; Wei QQ
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):631-4. PubMed ID: 24225299
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
    Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor.
    Aleem A; Saidu A; Abdulkarim H; Al-Diab AR; Al-Sagheer A; Qayum A; Al-Momen AK
    Haemophilia; 2009 Jan; 15(1):210-6. PubMed ID: 19149851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with rituximab in an elderly patient with acquired factor VIII inhibitor.
    Cretel E; Jean R; Chiche L; Durand JM
    Geriatr Gerontol Int; 2009 Jun; 9(2):197-9. PubMed ID: 19490140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in postpartum-related acquired hemophilia.
    Maillard H; Launay D; Hachulla E; Goudemand J; Lambert M; Morell-Dubois S; Queyrel V; Hatron PY
    Am J Med; 2006 Jan; 119(1):86-8. PubMed ID: 16431202
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VIII inhibitor eradication with bortezomib in acquired haemophilia A.
    McFadyen JD; Tran H; Kaplan ZS
    Br J Haematol; 2017 Sep; 178(6):986-987. PubMed ID: 27431860
    [No Abstract]   [Full Text] [Related]  

  • 11. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of factor VIII pharmacokinetics and anti-factor VIII antibodies in four boys with haemophilia A and a poor clinical response to factor VIII.
    Kempton CL; Meeks SL; Donald Harvey R; Abshire TC
    Haemophilia; 2011 Jan; 17(1):155-6. PubMed ID: 20579112
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of factor VIII inhibitors in two patients with moderate haemophilia A.
    Paschal RD; Meeks SL; Neff AT
    Haemophilia; 2013 Jan; 19(1):e55-7. PubMed ID: 23171275
    [No Abstract]   [Full Text] [Related]  

  • 14. Suggestions for the management of factor VIII inhibitors.
    Rubinger M; Rivard GE; Teitel J; Walker H;
    Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre.
    Chuansumrit A; Husapadol S; Wongwerawattanakoon P; Hongeng S; Sirachainan N; Pakakasama S
    Haemophilia; 2007 Jan; 13(1):108-10. PubMed ID: 17212736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision.
    Leblebisatan G; Sasmaz I; Antmen B; Kilinc Y; Sizmaz S; Yagmur M
    Haemophilia; 2006 Mar; 12(2):187-9. PubMed ID: 16476096
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis.
    Franchini M; Mengoli C; Lippi G; Targher G; Montagnana M; Salvagno GL; Zaffanello M; Cruciani M
    Haemophilia; 2008 Sep; 14(5):903-12. PubMed ID: 18671801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of incidence of inhibitors in patients with haemophilia.
    van der Bom JG; ter Avest P; Van den Berg HM; Psaty BM; Weiss NS
    Haemophilia; 2009 May; 15(3):707-11. PubMed ID: 19432923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in the treatment of acquired hemophilia.
    Stachnik JM
    Ann Pharmacother; 2006 Jun; 40(6):1151-7. PubMed ID: 16735671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.